Page last updated: 2024-08-25

zoledronic acid and Gout

zoledronic acid has been researched along with Gout in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aati, O; Chhana, A; Dalbeth, N; Doyle, AJ; Gamble, GD; Horne, A; House, ME; McQueen, FM; Reid, IR; Roger, M1
Aati, O; Callon, KE; Chhana, A; Cornish, J; Dalbeth, N; Doyle, AJ; Gamble, GD; Horne, A; McQueen, FM; Reid, IR; Roger, M1

Trials

2 trial(s) available for zoledronic acid and Gout

ArticleYear
Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:6

    Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Double-Blind Method; Female; Foot Bones; Gout; Humans; Imidazoles; Male; Middle Aged; Spine; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid

2014
Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout.
    The Journal of rheumatology, 2016, Volume: 43, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Bone and Bones; Bone Morphogenetic Proteins; Bone Remodeling; Diphosphonates; Female; Genetic Markers; Gout; Humans; Imidazoles; Male; Middle Aged; Osteoprotegerin; RANK Ligand; Zoledronic Acid

2016